Results 81 to 90 of about 1,333 (212)

Parasympathomimetic Effect of Shilajit Accounts for Relaxation of Rat Corpus Cavernosum [PDF]

, 2012
Sarabjeet Kaur, Pravin Kumar, Deo Kumar, M. D. Kharya, Nityanand Singh   +4 more
openalex   +1 more source

Salivary stimulation by prolonged release of pilocarpine in Sjögren’s syndrome [PDF]

, 2019
Introduction: Prolonged drug delivery in the oral cavity offers many advantages, such as reducing adverse effects. Pilocarpine is an FDA-approved parasympathomimetic drug for the treatment of glandular hypofunction; however, its adverse effects ...
Rodriguez Pulido, Jes´ús
core   +1 more source

Oral Complications from Oropharyngeal Cancer Therapy. [PDF]

Cancers (Basel), 2023
Sankar V, Xu Y.
europepmc   +1 more source

Skin Rash as a Side Effect of Bortezomib: A Case Report. [PDF]

Cureus, 2023
Khaldy M, Hamdan S, Amar M, Alshyoukhi M, Arafat H.   +4 more
europepmc   +1 more source

Histaminliberierung in Gl. submaxillaris und Pankreas durch Parasympathicomimetica, Peptidhormone, Histamin und Mepyramin [Histamine release in submaxillary gland and pancreas by parasympathomimetic drugs, peptide hormones, histamine and mepyramine]

, 1968
W Lorenz, G Haubensak, M. Hutzel, E Werle   +3 more
openalex   +1 more source

Effect of parasympathomimetic drugs on salivary flow rate

, 1997
Yoshihiko Tokiyasu, Shigeru Watanabe, Masatoshi Hirasawa, Seiji Suzuki, Kuniya Fujita, Masako Oda, Masahiko Takada   +6 more
openalex   +2 more sources

A Network Approach for the Study of Drug Prescriptions: Analysis of Administrative Records from a Local Health Unit (ASL TO4, Regione Piemonte, Italy) [PDF]

, 2021
Armando, Lg, Baroetto Parisi, R, Basso, L, Benetti, E, Cena, C., Miglio, G, Remani, E, Traina, S   +7 more
core   +1 more source

Trends in First-Line Glaucoma Treatment from 2013 to 2024: A Multi-institutional and Multinational Cohort Study. [PDF]

Ophthalmol Ther
Chuang LH, Tsai DH, Chan YH, Shao SC, Lai CC, Lai EC.   +5 more
europepmc   +1 more source

Drug Utilization, Adherence and Predictors of Drug-Changes and Discontinuation of Glaucoma Drug Therapies. [PDF]

Adv Ther
Novella A, Quaranta L, Pasina L, Galbussera AA, Tettamanti M, Fortino I, Leoni O, Weinreb RN, Nobili A.   +8 more
europepmc   +1 more source

Problems associated with the ATC system of drug classification. [PDF]

Naunyn Schmiedebergs Arch Pharmacol
Bindel LJ, Seifert R.
europepmc   +1 more source